Compare Canadian National Railway Co. (CNI) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian National Railway Co. vs Cronos Group Inc — how do they compare? Canadian National Railway Co. trades at $126.3 (market cap $76.28B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Canadian National Railway Co. is far larger — about 66.9× Cronos Group Inc's market cap, and Canadian National Railway Co. pays a 2.06% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CNI | CRON | |
|---|---|---|
Market Cap | $76.28B | $1.14B |
Sector | Industrials | Health |
52-Week High | $130.58 | $3.27 |
52-Week Low | $90.91 | $2.30 |
Enterprise Value | $92.31B | $341.13M |
Dividend Yield | 2.06% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canadian National Railway Co.
Canadian National's railway spans Canada from coast to coast and extends through Chicago to the Gulf of Mexico. In 2019, CN delivered almost 6 million carloads over its 19,600 miles of track. CN generated roughly CAD 14 billion in total revenue by hauling intermodal containers (25% of consolidated revenue), petroleum and chemicals (21%), grain and fertilizers (16%), forest products (12%), metals and mining (11%), automotive shipments (6%), and coal (4%). Other items constitute the remaining revenue.
Read more on CNI →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
